UKSNN research showcase seminar

3 December, 12:00 - 13:00 Online

Join us for an extra online session of the UK Symposium on Neuromodulation and Neurotechnology, hosted jointly by Neuromod+ and CloseNIT networks. This session will showcase the research of network awardees Wako Yoshida and Sophie Morse (talks postponed from the main symposium in September).

Joining details:

https://newcastleuniversity.zoom.us/j/88546378946 
passcode: 768982

Wako Yoshida: Adaptive closed-loop fMRI neurofeedback for social learning

Wako is a research fellow at the University of Oxford, working in computational cognitive and social sciences. She received her PhD from NAIST, and has worked at ATR, UCL and Cambridge University, and worked as an Associate Professor at Kyoto University prior to joining Oxford University. Her research addresses the computational neuroscience of human cognitive decision making and social interaction, with a particular focus on the function of the prefrontal cortex. In recent years, she has been involved in a number of research projects, including ‘hyperscanning’, in which two subjects interact (cooperate) in separate fMRI scanners to solve tasks together; real-time neurofeedback experiments on social learning; VR experiments to understand learning mechanisms during sleep; and human brain during complex decision-making tasks. Her team is engaged in research to elucidate human brain activity during complex decision-making tasks.

Sophie Morse: A Device for Ultrasound Modulation with Multi-Photon Imaging

Sophie completed her PhD in Bioengineering at Imperial College London, developing a non-invasive focused ultrasound technology to deliver drugs to the brain efficiently and safely. She was then awarded an EPSRC doctoral prize fellowship and has more recently become an Imperial College Research Fellow and an Emerging Leader within the UK Dementia Research Institute. She currently leads an interdisciplinary group at Imperial focused on modulating the activity of glial cells in the brain to delay and treat brain diseases.